Research programme: biotherapeutics - Gene Techno Science

Drug Profile

Research programme: biotherapeutics - Gene Techno Science

Alternative Names: GBS-002; GBS-003; GBS-006; GBS-007; GBS-009; GND-001; GND-002; GND-003; GND-004; GND-005

Latest Information Update: 29 Aug 2016

Price : $50

At a glance

  • Originator Gene Techno Science
  • Class Antibodies
  • Mechanism of Action Immunomodulators; Integrin alpha9 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cancer; Immunological disorders
  • Research Eye disorders
  • Discontinued Cardiovascular disorders

Most Recent Events

  • 29 Aug 2016 Discontinued for Cardiovascular disorders in Japan (unspecified route)
  • 06 Oct 2015 Development for Cancer and Immunological disorders is ongoing in Japan
  • 12 Jul 2011 Preclinical trials in Cancer in Japan (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top